IBBQ Among Technology ETFs
End-of-day Nov 20, 2026 · 58 Technology ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.7% | −6.0% | −4.0% | −6.5% | +19.2% | +22.5% | +83.1% | +44.5% | — | +38.1% |
| Peer average | −5.6% | −11.2% | −14.8% | −18.1% | −5.7% | −2.0% | +47.3% | +12.2% | +330.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$94 of every $1,000 in IBBQ is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 9.41% | $940.85 | 70K | $11.7M |
| 2 | AMGNAmgen | Healthcare | 8.44% | $844.02 | 24K | $10.5M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 7.91% | $790.60 | 19K | $9.8M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 6.32% | $632.04 | 8,498 | $7.8M |
| 5 | MRNAModerna | Healthcare | 5.39% | $538.57 | 34K | $6.7M |
| 6 | BIIBBiogen | Healthcare | 2.47% | $247.14 | 12K | $3.1M |
| 7 | RVMDRevolution Medicines | Healthcare | 2.31% | $231.29 | 18K | $2.9M |
| 8 | INSMInsmed | Healthcare | 2.14% | $213.53 | 18K | $2.7M |
| 9 | ILMNIllumina | Healthcare | 2.05% | $204.94 | 13K | $2.5M |
| 10 | RPRXRoyalty Pharma | Healthcare | 2.04% | $203.87 | 37K | $2.5M |
| 11 | ROIVRoivant Sciences | Healthcare | 1.90% | $190.44 | 61K | $2.4M |
| 12 | ARGNFArgenx SE | — | 1.74% | $173.92 | 2,292 | $2.2M |
| 13 | UTHRUnited Therapeutics | Healthcare | 1.62% | $162.31 | 3,604 | $2.0M |
| 14 | INCYIncyte | Healthcare | 1.59% | $158.87 | 17K | $2.0M |
| 15 | VTRSViatris | Healthcare | 1.54% | $154.28 | 96K | $1.9M |
of the $345B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 9.41% |
| 2 | AMGN | Amgen | 8.44% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.91% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.32% |
| 5 | MRNA | Moderna | 5.39% |
| 6 | BIIB | Biogen | 2.47% |
| 7 | RVMD | Revolution Medicines | 2.31% |
| 8 | INSM | Insmed | 2.14% |
| 9 | ILMN | Illumina | 2.05% |
| 10 | RPRX | Royalty Pharma | 2.04% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.23 |
| Jun 22, 2026 | Jun 26, 2026 | $0.0342 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0361 |
| Dec 22, 2025 | Dec 26, 2025 | $0.0906 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0958 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0287 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0402 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0619 |
| Sep 23, 2024 | Sep 27, 2024 | $0.0894 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0506 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0435 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0526 |